Bleeding avoidance strategies in percutaneous coronary intervention
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bleeding avoidance strategies in percutaneous coronary intervention
Authors
Keywords
-
Journal
Nature Reviews Cardiology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-08-23
DOI
10.1038/s41569-021-00598-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation
- (2021) Philip Urban et al. JAMA Cardiology
- Radial versus femoral access for coronary interventions: An updated systematic review and meta‐analysis of randomized trials
- (2021) Mauro Chiarito et al. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
- Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention
- (2021) Dominick J. Angiolillo et al. CIRCULATION
- Primary Results of the EVOLVE Short DAPT Study
- (2021) Ajay J. Kirtane et al. Circulation-Cardiovascular Interventions
- Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI
- (2021) Marco Valgimigli et al. JACC-Cardiovascular Interventions
- Evidence and Recommendations for Uninterrupted Versus Interrupted Oral Anticoagulation in Patients Undergoing Percutaneous Coronary Intervention
- (2021) Piera Capranzano et al. JACC-Cardiovascular Interventions
- Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial
- (2021) Benjamin E. Peterson et al. JACC-Cardiovascular Interventions
- Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
- (2021) Mattia Galli et al. LANCET
- Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease
- (2021) Katharina Mayer et al. JAMA Cardiology
- Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease
- (2020) Davide Capodanno et al. Nature Reviews Cardiology
- Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk
- (2020) Stephan Windecker et al. NEW ENGLAND JOURNAL OF MEDICINE
- EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
- (2020) Michael Glikson et al. EuroIntervention
- Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention
- (2020) John H. Alexander et al. CIRCULATION
- Global Approach to High Bleeding Risk Patients With Polymer-Free Drug-Coated Coronary Stents
- (2020) Mitchell W. Krucoff et al. Circulation-Cardiovascular Interventions
- Selatogrel, a novel P2Y12 inhibitor: a review of the pharmacology and clinical development
- (2020) Rocco P. Milluzzo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Optimal Timing of Intervention in NSTE-ACS Without Pre-Treatment
- (2020) Gilles Lemesle et al. JACC-Cardiovascular Interventions
- Subcutaneous Selatogrel Inhibits Platelet Aggregation in Patients With Acute Myocardial Infarction
- (2020) Peter Sinnaeve et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial
- (2020) Marieke Gimbel et al. LANCET
- Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes
- (2020) Maurizio Menichelli et al. ANNALS OF INTERNAL MEDICINE
- Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis
- (2020) Safi U. Khan et al. CIRCULATION
- The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y 12 Inhibitor in Patients After Percutaneous Coronary Intervention
- (2020) Michelle L. O’Donoghue et al. CIRCULATION
- Self-treatment for acute coronary syndrome: why not?
- (2020) Sebastien Roux et al. EUROPEAN HEART JOURNAL
- Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome
- (2020) Byeong-Keuk Kim et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients
- (2020) Davide Cao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- New Antithrombotic Drugs in Acute Coronary Syndrome
- (2020) Bastiaan Zwart et al. Journal of Clinical Medicine
- 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- (2020) Jean-Philippe Collet et al. EUROPEAN HEART JOURNAL
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)
- (2020) Gerhard Hindricks et al. EUROPEAN HEART JOURNAL
- Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk
- (2020) Noé Corpataux et al. EUROPEAN HEART JOURNAL
- Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention
- (2020) Naveen L. Pereira et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI
- (2020) Davide Capodanno et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Timing of Oral P2Y12 Inhibitor Administration in Non-ST Elevation Acute Coronary Syndrome
- (2020) Giuseppe Tarantini et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial
- (2020) Hyo-Soo Kim et al. LANCET
- Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores
- (2020) Yasushi Ueki et al. EuroIntervention
- Ticagrelor alone or conventional dual antiplatelet therapy in patients with stable or acute coronary syndromes
- (2020) Anna Franzone et al. EuroIntervention
- Helicobacter pylori screening in clinical routine during hospitalization for acute myocardial infarction
- (2020) Jonatan Wärme et al. AMERICAN HEART JOURNAL
- 1-Year Safety of 3-Month Dual Antiplatelet Therapy Followed by Aspirin or P2Y12 Receptor Inhibitor Monotherapy Using a Bioabsorbable Polymer Sirolimus-Eluting Stent
- (2020) Ken Kozuma et al. CIRCULATION JOURNAL
- Meta-Analysis of Transradial vs Transfemoral Access for Percutaneous Coronary Intervention in Patients With ST Elevation Myocardial Infarction
- (2020) Aravdeep Jhand et al. AMERICAN JOURNAL OF CARDIOLOGY
- Platelet Inhibition with Cangrelor and Crushed Ticagrelor in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of the CANTIC Study
- (2019) Francesco Franchi et al. CIRCULATION
- 2018 ESC/EACTS Guidelines on myocardial revascularization
- (2019) Franz-Josef Neumann et al. EuroIntervention
- Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers
- (2019) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
- (2019) Renato D. Lopes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting
- (2019) Francesco Costa et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pantoprazole to Prevents Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-blind, Placebo-controlled Trial
- (2019) P. Moayyedi et al. GASTROENTEROLOGY
- Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention
- (2019) Philip Urban et al. CIRCULATION
- Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention
- (2019) Dirk Sibbing et al. JACC-Cardiovascular Interventions
- Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention
- (2019) Joo-Yong Hahn et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
- (2019) Hirotoshi Watanabe et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI
- (2019) Davide Capodanno et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
- (2019) Juhani Knuuti et al. EUROPEAN HEART JOURNAL
- Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid–aspirin complex: results of a randomized, crossover, bioequivalence study
- (2019) Dominick J. Angiolillo et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Dual antithrombotic therapy for atrial fibrillation and PCI
- (2019) Davide Capodanno et al. LANCET
- Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial
- (2019) Pascal Vranckx et al. LANCET
- Ticagrelor with or without Aspirin in High-Risk Patients after PCI
- (2019) Roxana Mehran et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI
- (2019) Daniel M.F. Claassens et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
- (2019) Stefanie Schüpke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention
- (2019) Masahiro Natsuaki et al. Circulation-Cardiovascular Interventions
- Bleeding after antiplatelet therapy for the treatment of acute coronary syndromes: a review of the evidence and evolving paradigms
- (2019) Sergio Buccheri et al. Expert Opinion On Drug Safety
- Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting
- (2019) Anna Franzone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation: a nationwide study
- (2019) Anne-Marie Schjerning Olsen et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and Methodology
- (2019) Behnood Bikdeli et al. THROMBOSIS AND HAEMOSTASIS
- Incidence, Predictors, and Outcomes of Acquired Thrombocytopenia After Percutaneous Coronary Intervention
- (2018) Elliott M. Groves et al. Circulation-Cardiovascular Interventions
- Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score
- (2018) Sergio Raposeiras-Roubín et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- 6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial
- (2018) Joo-Yong Hahn et al. LANCET
- Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial
- (2018) Olivier Varenne et al. LANCET
- Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention
- (2018) Davide Capodanno et al. Nature Reviews Cardiology
- Safety of six-month dual antiplatelet therapy after second-generation drug-eluting stent implantation: OPTIMA-C Randomised Clinical Trial and OCT Substudy
- (2018) Byoung-Kwon Lee et al. EuroIntervention
- Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores
- (2018) Masahiro Natsuaki et al. Journal of the American Heart Association
- Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
- (2018) Pascal Vranckx et al. LANCET
- Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial
- (2018) Marco Valgimigli et al. LANCET
- Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation with an abbreviated versus standard DAPT regimen (MASTER DAPT) study
- (2018) Enrico Frigoli et al. AMERICAN HEART JOURNAL
- ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy
- (2018) Davide Capodanno et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial
- (2018) Elvin Kedhi et al. BMJ-British Medical Journal
- Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study
- (2017) Thomas Cuisset et al. EUROPEAN HEART JOURNAL
- 6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin
- (2017) Romain Didier et al. JACC-Cardiovascular Interventions
- Dual Antiplatelet Therapy for 6 Versus 18 Months After Biodegradable Polymer Drug-Eluting Stent Implantation
- (2017) Masato Nakamura et al. JACC-Cardiovascular Interventions
- Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography–Guided Percutaneous Coronary Intervention With Stent Implantation
- (2017) Sergio Buccheri et al. JACC-Cardiovascular Interventions
- Management and outcome of gastrointestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs
- (2017) Sven Pannach et al. JOURNAL OF GASTROENTEROLOGY
- Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus
- (2017) Deepak L. Bhatt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease
- (2017) Manesh R. Patel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI
- (2017) Gennaro Giustino et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
- (2017) Muthiah Vaduganathan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Tailoring duration of DAPT with risk scores
- (2017) Davide Capodanno et al. LANCET
- Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials
- (2017) Francesco Costa et al. LANCET
- Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial
- (2017) Dirk Sibbing et al. LANCET
- Bivalirudin versus Heparin Monotherapy in Myocardial Infarction
- (2017) David Erlinge et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
- (2017) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors
- (2017) Muthiah Vaduganathan et al. JAMA Cardiology
- Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable Polymer Sirolimus-Eluting Stent
- (2016) Yaling Han et al. Circulation-Cardiovascular Interventions
- Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding
- (2016) Wayne A. Ray et al. GASTROENTEROLOGY
- Radial Access Reduces Mortality in Patients With Acute Coronary Syndromes
- (2016) Giuseppe Andò et al. JACC-Cardiovascular Interventions
- Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?
- (2016) Sara Ariotti et al. JACC-Cardiovascular Interventions
- 6-Month Versus 12-Month Dual-Antiplatelet Therapy Following Long Everolimus-Eluting Stent Implantation
- (2016) Sung-Jin Hong et al. JACC-Cardiovascular Interventions
- Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease
- (2016) Giuseppe Ferrante et al. JACC-Cardiovascular Interventions
- Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention
- (2016) Robert W. Yeh et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents
- (2016) Usman Baber et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Arterial access and arteriotomy site closure devices
- (2016) Sunil V. Rao et al. Nature Reviews Cardiology
- Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
- (2016) C. Michael Gibson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radial Versus Femoral Access in Invasively Managed Patients With Acute Coronary Syndrome
- (2015) Giuseppe Andò et al. ANNALS OF INTERNAL MEDICINE
- Pretreatment With Antiplatelet Drugs in Invasively Managed Patients With Coronary Artery Disease in the Contemporary Era: Review of the Evidence and Practice Guidelines
- (2015) D. Capodanno et al. Circulation-Cardiovascular Interventions
- ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting
- (2015) S. Schulz-Schupke et al. EUROPEAN HEART JOURNAL
- Novel Approaches for Preventing or Limiting Events (Naples) III Trial
- (2015) Carlo Briguori et al. JACC-Cardiovascular Interventions
- Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation
- (2015) Katrin A. Fiedler et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trials
- (2015) Dominick J. Angiolillo et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes
- (2015) Marco Valgimigli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk
- (2015) Philip Urban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bivalirudin for acute coronary syndromes: premises, promises and doubts
- (2015) Davide Capodanno et al. THROMBOSIS AND HAEMOSTASIS
- Pretreatment With P2Y 12 Inhibitors in Non–ST-Segment–Elevation Acute Coronary Syndrome Is Clinically Justified
- (2014) Marco Valgimigli CIRCULATION
- Second-Generation Drug-Eluting Stent Implantation Followed by 6- Versus 12-Month Dual Antiplatelet Therapy
- (2014) Antonio Colombo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial
- (2014) Adeel Shahzad et al. LANCET
- Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction
- (2014) Gilles Montalescot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
- (2014) Laura Mauri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stent Thrombosis With Drug-Eluting Stents
- (2013) Tullio Palmerini et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Why Are We Still Using Coronary Bare-Metal Stents?
- (2013) Marie-Claude Morice et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Triple Therapy With Aspirin, Prasugrel, and Vitamin K Antagonists in Patients With Drug-Eluting Stent Implantation and an Indication for Oral Anticoagulation
- (2013) Nikolaus Sarafoff et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparison of Prasugrel and Ticagrelor Loading Doses in ST-Segment Elevation Myocardial Infarction Patients
- (2013) Guido Parodi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
- (2013) Willem JM Dewilde et al. LANCET
- Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data
- (2013) Philippe Gabriel Steg et al. LANCET
- Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
- (2013) Gilles Montalescot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug Resistance and Pseudoresistance
- (2012) Tilo Grosser et al. CIRCULATION
- A New Strategy for Discontinuation of Dual Antiplatelet Therapy
- (2012) Byeong-Keuk Kim et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Temporal Trends in and Factors Associated With Bleeding Complications Among Patients Undergoing Percutaneous Coronary Intervention
- (2012) Sumeet Subherwal et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents
- (2011) Hyeon-Cheol Gwon et al. CIRCULATION
- Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial
- (2011) Gilles Montalescot et al. LANCET
- A Prospective Natural-History Study of Coronary Atherosclerosis
- (2011) Gregg W. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-Dose Aspirin-Induced Ulceration Is Attenuated by Aspirin–Phosphatidylcholine: A Randomized Clinical Trial
- (2010) Byron Cryer et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis
- (2010) G. Ducrocq et al. EUROPEAN HEART JOURNAL
- A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes
- (2010) Roxana Mehran et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clopidogrel with or without Omeprazole in Coronary Artery Disease
- (2010) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction
- (2009) Sumeet Subherwal et al. CIRCULATION
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now